[ET Net News Agency, 16 July 2021] GENSCRIPT BIO (01548) rose 1.61% to HK$40.9.
It hits an intra-day high of HK$41, hitting a historical high, and an intra-day low of
HK$39.85. The total shares traded was 3.34 million, with a value of HK$134.64m. The active
buy/sell ratio is 51:49, with net buying turnover of HK$2.66m. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$10.69m, with volume weighted
average price of HK$40.222. J.P. MORGAN BRO (HK) accounts for greatest net responsive
selling turnover of HK$7.39m, with volume weighted average price of HK$40.278. The stock
has risen a combined 9.07% over the past 3 consecutive trading days.
The Hang Seng Index now rose 125 points, or 0.45% to 28,121; the Hang Seng China
Enterprises Index now rose 21 points, or 0.21% to 10,195; the Hang Seng TECH Index now
fell 9 points, or 0.13% to 7,651; with an overall turnover of HK$80.46b.
The SSE Composite Index now fell 5 points, or 0.15% to 3,559, with an overall turnover
of RMB337.36b.
The SZSE Component Index now fell 46 points, or 0.31% to 15,122, with an overall
turnover of RMB224.01b.

Basic Information
-------------------------------------------
Nominal 40.900 % Chg +1.61%
High 41.000 Low 39.850
Shares Tr 3.34m Turnover 134.64m
10-D SMA 37.070 %H.V 74.005
20-D SMA 35.432 VWAP 40.304
50-D SMA 30.305 RSI14 70.439
-------------------------------------------
Status: Hitting a historical high, active buy/sell ratio is 51:49, with net buying
turnover of HK$2.66m, rising a combined 9.07% over the past 3 consecutive
trading days

Table: Performance of stocks in the same sector or of relevance

Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
GENSCRIPT BIO (01548) 40.90 +1.61
HUTCHMED (00013) 66.75 +10.24
INNOVENT BIO (01801) 88.50 +0.34
JXR (01951) 16.12 -3.36
WUXI BIO (02269) 139.60 +1.38
CANSINOBIO-B (06185) 316.40 -0.94
ASCENTAGE-B (06855) 48.35 -7.82
KINTOR PHARMA-B (09939) 65.55 +5.64
KINDSTAR GLOBAL (09960) 9.10 -
ALPHAMAB-B (09966) 25.70 -4.64
-------------------------------------------------
(ed)